Industry Round-Up
And finally this week, a quick round-up of other industry movers and shakers:
Dr. Eddie Li has joined Intarcia Therapeutics from Novo Nordisk as Vice President and Global Head of Regulatory Affairs.
Lyndon Nicholson is the new Chief Executive at WinchPharma, replacing Philip McSweeney.
Avaxia Biologics has appointed Dr. Neil Schauer as Vice President, Technical Operations, responsible for or process development, manufacturing, formulation, and quality for the entire Avaxia product candidate pipeline.
Flint Besecker has joined Kinex Pharmaceuticals as Chief Financial Officer.